City

Barakaldo (1)

Singapore (1)

Stockholm (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Phase

n/a (1)

phase 2 (1)

Sponsor

Region Stockholm (1)

S-There Technologies SL (1)

Singapore General Hospital (1)

Collaborator

Biocruces Bizkaia Health Research Institute (1)

Hospital de Cruces (1)

Singapore Eye Research Institute (1)

Intervention

darbepoietin alfa (1)

diabetes microvascular complication tests (1)

lab gold standard (1)

roxadustat (1)

s-there (1)

Study Documents

Intervention Type

device (1)

diagnostic test (1)

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

diabetes; nephropathy (manifestation)

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetes Complications, Diabetes; Nephropathy (Manifestation) Trial in Stockholm (Roxadustat, Darbepoietin Alfa)

Not yet recruiting

Diabetes Complications
Diabetes; Nephropathy (Manifestation)

Roxadustat
Darbepoietin Alfa

Stockholm, Sweden

Centre for diabetes

Apr 11, 2023

Stratification of Type 2 Diabetes Microvascular Complications

Recruiting

Type 2 Diabetes
+4 more

Diabetes Microvascular Complication Tests

Singapore, Singapore

Singapore General Hospital

Mar 14, 2023

Renal Insufficiency, Chronic, Heart Failure, Diabete Mellitus Trial in Barakaldo (Lab Gold Standard, S-There)

Unknown status

Renal Insufficiency, Chronic
+5 more

Lab Gold Standard
S-There

Barakaldo, Bizkaia, Spain

Hospital de Cruces

Dec 4, 2019